under construction

For People with Advanced MS

  • Twitter
  • YouTube
  • Instagram

CHARIOTMS is a groundbreaking  clinical trial.

It will test whether Cladribine Tablets (MAVENCLAD©), an established treatment for highly active relapsing MS, can preserve upper limb function in Advanced MS, where people have largely lost the ability to walk.

These are the 44% of people with MS who currently have very limited  treatment options.

CHARIOTMS is the first disease modifying treatment trial for wheechair users .

CHARIOTMS is the first trial with no upper age limit.

 

videoicon4.png
Prof Klaus Schmierer,
Chief Investigator, Chariot
MS
THE TRIAL

THE  SCIENCE

Screenshot 2021-02-14 at 12.23.34.png

COMMMUNITY

Screenshot 2021-02-14 at 12.35.14.png
Trial Information
Screenshot 2021-02-14 at 12.35.14.png
Trial Locations
wheelchairanddumbell.png

Advanced MS

mc.jpg

Cladribine
 

The Team

Barts NHS Health Trust

SARS-CoV2  Risk  Mitigation (PDF tba

Check your local NHS Trustfor updates